US Broker Ratings

Globus Medical, Inc. (GMED) Investor Outlook: Exploring a 45.49% Potential Upside Amid Strong Revenue Growth

Globus Medical, Inc. (NYSE: GMED), a prominent name in the healthcare sector, specifically within the medical devices industry, presents a compelling investment opportunity for individual investors. The company, with a..

Ascendis Pharma A/S (ASND) Stock Analysis: Impressive Revenue Growth and Strong Buy Ratings Signal a Promising Future

Ascendis Pharma A/S (NASDAQ: ASND) stands as a shining beacon in the biotechnology sector, capturing the attention of investors with its remarkable revenue growth and an overwhelmingly positive analyst outlook...

Avantor, Inc. (AVTR) Stock Analysis: Exploring Growth Potential with a 29% Upside

Avantor, Inc. (NYSE: AVTR), headquartered in Radnor, Pennsylvania, remains a significant player in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $5.2..

Koninklijke Philips N.V. (PHG) Investor Outlook: Navigating a 32.94% Potential Upside in the Healthcare Sector

As investors seek promising opportunities in the healthcare sector, Koninklijke Philips N.V. (PHG) presents a compelling case with a potential upside of 32.94%. While the company has faced challenges, its..

Align Technology, Inc. (ALGN) Stock Analysis: A 32.95% Potential Upside in the Healthcare Sector

Align Technology, Inc. (NASDAQ: ALGN) is drawing significant attention from investors, thanks to its promising growth prospects in the healthcare sector. Specializing in medical instruments and supplies, Align Technology is..

Cardinal Health, Inc. (CAH)

⚠️ No article content returned.

..

Solventum Corporation (SOLV) Stock Analysis: Exploring a 10.53% Upside in the Healthcare Sector

Solventum Corporation (NYSE: SOLV), a prominent player in the healthcare sector, has captured investor attention with its potential upside of 10.53%. As a key entity within the Medical Instruments &..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Unlocking a 56.62% Potential Upside with Strong Buy Ratings

Investors eyeing the biotechnology sector should pay close attention to Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a company renowned for its pioneering role in ribonucleic acid interference (RNAi) therapeutics. With a..

Charles River Laboratories (CRL): Investor Outlook Unveils 38.42% Potential Upside

Charles River Laboratories International, Inc. (NYSE: CRL), a prominent player in the Healthcare sector, particularly within the Diagnostics & Research industry, presents a compelling opportunity for investors seeking growth in..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating Growth and Potential Upside

Medpace Holdings, Inc. (NASDAQ: MEDP) stands as a formidable player in the healthcare sector, specifically in the diagnostics and research industry. Headquartered in Cincinnati, Ohio, Medpace provides a comprehensive range..

Chemed Corp (CHE) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential with a 2.75% Upside

Chemed Corp (NYSE: CHE), a leader in the healthcare sector, continues to capture investor attention due to its solid foothold in the medical care facilities industry. With a market capitalization..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Evaluating a 23.24% Upside Potential with Strong Buy Ratings

Takeda Pharmaceutical Company Limited (NYSE: TAK) has emerged as a significant player in the global healthcare sector, particularly within the specialty and generic drug manufacturing industry. Headquartered in Tokyo, Japan,..

Exact Sciences Corporation (EXAS)

⚠️ No article content returned.

..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring an 18.46% Upside Potential in the Healthcare Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the medical devices industry, is commanding the attention of investors with a potential upside of 18.46%, according to recent..

Mettler-Toledo International (MTD) Stock Analysis: Exploring a Potential 30% Upside for Investors

Mettler-Toledo International Inc. (NYSE: MTD), a key player in the Healthcare sector’s Diagnostics & Research industry, commands investor attention with its specialized precision instruments and expansive global reach. Headquartered in..

Abbott Laboratories (ABT) Stock Analysis: Unlocking a 40% Potential Upside for Savvy Investors

Abbott Laboratories (NYSE: ABT) is a healthcare giant with a market capitalization of $147.13 billion, operating in the medical devices industry. As a company with a rich history dating back..

Baxter International Inc. (BAX) Stock Analysis: Exploring a 27.83% Potential Upside Amidst Healthcare Sector Dynamics

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $8.93 billion, the company is a..

HealthEquity, Inc. (HQY) Stock Analysis: Analysts See Potential 37% Upside

HealthEquity, Inc. (NASDAQ: HQY), a leader in the health information services sector, presents an intriguing investment opportunity with a potential upside of 37.37%, according to analyst ratings. With a market..

Doximity, Inc. (DOCS) Stock Analysis: Unpacking the 32.58% Potential Upside

Doximity, Inc. (NYSE: DOCS) is carving a niche within the digital health space, serving as a pivotal platform for medical professionals across the United States. With a market capitalization of..

Insmed Incorporated (INSM): Investor Outlook Reveals 84% Upside Potential Amidst Biotech Innovations

Insmed Incorporated (NASDAQ: INSM), a frontrunner in the biotechnology sector, continues to capture investor attention with its robust pipeline of therapies targeting serious and rare diseases. Headquartered in Bridgewater, New..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds